ARK Genomic Revolution ETF
ARKG
514 hedge funds and large institutions have $2.37B invested in ARK Genomic Revolution ETF in 2021 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 203 increasing their positions, 156 reducing their positions, and 60 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 203 | Existing positions reduced: 156
13% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 60
6% more capital invested
Capital invested by funds: $2.24B → $2.37B (+$137M)
1% more funds holding
Funds holding: 508 → 514 (+6)
0.87% more ownership
Funds ownership: 23.65% → 24.52% (+0.87%)
12% less funds holding in top 10
Funds holding in top 10: 17 → 15 (-2)
48% less call options, than puts
Call options by funds: $470M | Put options by funds: $904M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$49.1M |
| 2 |
Goldman Sachs
New York
|
+$33.7M |
| 3 |
HF
HRT Financial
New York
|
+$30.8M |
| 4 |
LFA
Legend Financial Advisors
Pittsburgh,
Pennsylvania
|
+$15.5M |
| 5 |
Jane Street
New York
|
+$12.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$34.7M |
| 2 |
PI
PEAK6 Investments
Chicago,
Illinois
|
-$17.9M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$15.9M |
| 4 |
Morgan Stanley
New York
|
-$14M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11M |
ARKG Hedge Fund Activity: Q2 2021 in Review
514 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2021, worth a combined $2.37B — up 6.1% from $2.24B a quarter earlier.
Buyers outnumbered sellers: 68 funds opened new ARKG positions and 60 closed out — a net gain of 8 holders — while 203 added to existing stakes and 156 trimmed.
The largest buyer was Bank of America, adding an estimated $49.1M. The largest seller was OMERS Administration Corp, exiting entirely with an estimated $34.7M sold.
- 514 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2021, up from 508 in Q1 2021.
- Funds reported $2.37B of ARK Genomic Revolution ETF stock for Q2 2021, up 6.1% quarter-over-quarter.
- 68 funds opened new ARK Genomic Revolution ETF positions in Q2 2021 and 60 closed out, a net change of +8 holders.
- The largest ARK Genomic Revolution ETF buyer in Q2 2021 was Bank of America, an estimated $49.1M added.
- The largest ARK Genomic Revolution ETF seller in Q2 2021 was OMERS Administration Corp, an estimated $34.7M sold.
Based on aggregated 13F filings for Q2 2021.